Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer

Abstract Aims To report the role of total pelvic exenteration in a series of locally advanced and recurrent rectal cancers. Methods In the period 1994–2004, TPE was performed in 35 of 296 patients with primary locally advanced and recurrent rectal cancer treated in the Daniel den Hoed Cancer Center;...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2007-05, Vol.33 (4), p.452-458
Hauptverfasser: Vermaas, M, Ferenschild, F.T.J, Verhoef, C, Nuyttens, J.J.M.E, Marinelli, A.W.K.S, Wiggers, T, Kirkels, W.J, Eggermont, A.M.M, de Wilt, J.H.W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Aims To report the role of total pelvic exenteration in a series of locally advanced and recurrent rectal cancers. Methods In the period 1994–2004, TPE was performed in 35 of 296 patients with primary locally advanced and recurrent rectal cancer treated in the Daniel den Hoed Cancer Center; 23 of 176 with primary locally advanced and 12 of 120 with recurrent rectal cancer. All but one patient received pre-operative External Beam Radiation Therapy (EBRT). After 1997, Intra Operative Radiotherapy (IORT) was performed in case of a resection margin less than 2 mm. Results Overall major complication rates were not significantly different between patients with primary and recurrent rectal cancer (26% vs. 50%, p = 0.94). The hospital mortality rate was 3%. The 5-year local control and overall survival of patients with primary locally advanced rectal cancer were 88% and 52%, respectively. In patients with recurrent rectal cancer 3-year local control and survival rates were 60% and 32%, respectively. An incomplete resection, preoperative pain and advanced Wanebo stage for recurrent cancer were negative prognostic factors for both local control and overall survival. Conclusion TPE in primary locally advanced rectal cancer enables good local control and acceptable overall survival, thereby justifying the use of the procedure. Patients with recurrent rectal cancer showed a high rate of major complications, a high distant metastasis rate, and a poor overall survival.
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2006.09.021